EMA prepares for Brexit, as EC fires the starting gun for beauty parade of new locations
The application procedure to host the two UK-based European Union agencies, the European Medicines Agency (EMA) and the European Banking Authority (EBA), came to a close at midnight on July 31, 2017, the European Commission announced yesterday, thus firing the starting gun for bids from various European cities to become the location for these important regulatory agencies. Some 19 cities have posted formal bids to host the EMA after Brexit.
The Commission's assessment will be published online on September 30. The Council will then have a political discussion based on this assessment at the General Affairs Council (Article 50 format) in October 2017.
Meantime, the European Medicines Agency itself has developed and initiated a business continuity plan to deal with the uncertainty and workload implications linked to the UK’s withdrawal from the European Union and the Agency’s relocation.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
More on this story...
Today's issue
Company Spotlight
More Features in Pharmaceutical
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze